Thematic Champions in the UK

Janet Hemingway is Professor of Tropical Medicine at the Liverpool School of Tropical Medicine (LSTM) and founding Director of the Infection Innovation Consortium (iiCON). Responding to the growing challenge of infectious diseases, antimicrobial resistance, and emerging pandemics, iiCON brings together academic, industry, and clinical partners in a £170 million programme to transform the discovery and supply of much-needed anti-infectives and accelerate their journey to market.
She is a senior technical advisor on Neglected Tropical Diseases for the Bill and Melinda Gates
Foundation and has been PI on projects in excess of £370 million including the BMGF funded
Innovative Vector Control Consortium, the ERDF funded Formulations programme and the BMGF
funded Visceral Leishmaniasis Elimination programme. Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down on 1st January 2019. She was awarded a CBE for services to the Control of Tropical Disease Vectors in 2012.

Till Bachmann is an expert in point of care detection of infectious diseases and antimicrobial resistance, conducting research at the interface of biomarkers and novel detection modalities. Currently, he focuses on electrochemical POCTs for CPE and MRSA, sepsis, UTI, and wound infection, as well as isothermal amplification driven by electrochemistry. Till fulfills a variety of industrial and institutional advisory roles worldwide.

Calman MacLennan is professor of Vaccine Immunology at the University of Birmingham. He is MRC Senior Clinical Fellow, Jenner Investigator and Group Leader – Gonococcal Vaccine Project at the Jenner Institute. Calman is also Senior Program Officer Bacterial Vaccines and Lead – Shigella Portfolio & Salmonella Vaccines Product Development, Global Health – Enteric & Diarrheal Diseases, Bill & Melinda Gates Foundation. Calman is director, BactiVac Bacterial Vaccinology Network; Consultant Immunologist at Oxford University Hospitals NHS Trust.